2023
DOI: 10.1016/j.jacep.2022.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(23 citation statements)
references
References 20 publications
0
21
0
Order By: Relevance
“…They demonstrated similar change in LVEF and complication rates, with a greater reduction in QRS duration with CSP (delta QRS duration 32 ± 29 ms vs 14 ± 25 ms; p = 0.03). (Moore et al, 2022). It is likely that the near future will bring further advances in our understanding of the role of CSP in CRT for pediatric and CHD.…”
Section: Csp For Cardiac Resynchronization Therapymentioning
confidence: 99%
See 4 more Smart Citations
“…They demonstrated similar change in LVEF and complication rates, with a greater reduction in QRS duration with CSP (delta QRS duration 32 ± 29 ms vs 14 ± 25 ms; p = 0.03). (Moore et al, 2022). It is likely that the near future will bring further advances in our understanding of the role of CSP in CRT for pediatric and CHD.…”
Section: Csp For Cardiac Resynchronization Therapymentioning
confidence: 99%
“…Overall, in a recent multicenter study of CSP in CHD, 14 out of the 17 HSP were performed using the Medtronic C315H catheter, with only one utilizing the steerable C304H sheath. (Moore et al, 2022). Again, Boston Scientific (such as SSP3 sheath) and Biotronik (Selectra 3D) also produce appropriate sheaths, but these have been less widely employed in the pediatric and CHD cohorts.…”
Section: Equipment and Implantmentioning
confidence: 99%
See 3 more Smart Citations